Fig. 3From: Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial“Pearl-like” RCCEP skin nodule histopathology and molecular marker detection. a Immunohistochemistry. b Immunofluorescence co-staining (red, VEGF-A; green, CD163; and blue, DAPI. Arrow: M2 macrophages expressing VEGF-A). RCCEP, reactive cutaneous capillary endothelial proliferationBack to article page